High transmissibility of COVID-19 near symptom onset

Author:

Cheng Hao-Yuan,Jian Shu-Wan,Liu Ding-Ping,Ng Ta-ChouORCID,Huang Wan-Ting,Lin Hsien-HoORCID,

Abstract

AbstractBackgroundThe dynamics of coronavirus disease 2019 (COVID-19) transmissibility after symptom onset remains unknown.MethodsWe conducted a prospective case-ascertained study on laboratory-confirmed COVID-19 cases and their contacts. Secondary clinical attack rate (considering symptomatic cases only) was analyzed for different exposure windows after symptom onset of index cases and for different exposure settings.ResultsThirty-two confirmed patients were enrolled and 12 paired data (index-secondary cases) were identified among the 1,043 contacts. The secondary clinical attack rate was 0.9% (95% CI 0.5–1.7%). The attack rate was higher among those whose exposure to index cases started within five days of symptom onset (2.4%, 95% CI 1.1–4.5%) than those who were exposed later (zero case from 605 close contacts, 95% CI 0–0.61%). The attack rate was also higher among household contacts (13.6%, 95% CI 4.7–29.5%) and non- household family contacts (8.5%, 95% CI 2.4–20.3%) than that in healthcare or other settings. The higher secondary clinical attack rate for contacts near symptom onset remained when the analysis was restricted to household and family contacts. There was a trend of increasing attack rate with the age of contacts (p for trend < 0.001).ConclusionsHigh transmissibility of COVID-19 near symptom onset suggests that finding and isolating symptomatic patients alone may not suffice to contain the epidemic, and more generalized social distancing measures are required. Rapid reduction of transmissibility over time implies that prolonged hospitalization of mild cases might not be necessary in large epidemics.

Publisher

Cold Spring Harbor Laboratory

Reference28 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China;N Engl J Med,2019

2. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report — 48 [Internet]. World Health Organization. 2020 [cited 2020 Mar 8]; Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4

3. Lipsitch M , Swerdlow DL , Finelli L. Defining the Epidemiology of Covid-19 - Studies Needed. N Engl J Med 2020.

4. Nishiura H , Linton NM , Akhmetzhanov AR . Serial interval of novel coronavirus (COVID-19) infections. International Journal of Infectious Diseases 2020.

5. Zou L , Ruan F , Huang M , et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3